Sharing Life Sciences Innovations

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

JLABS event: Going Up - Successful Elevator Pitches and Investor Interactions

Radisson Blu Astrid Hotel Koningin Astridplein 7 Antwerp 2018
Wed 03 Apr 2019
11:30

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for an in-depth workshop on navigating relations with investors. In this works…

Read more

Global Engage Microbiome & Probiotics Series: Europe

Rotterdam, The Netherlands (venue TBA)
Mon 20 May 2019 - Wed 22 May 2019
20 May 08:00 - 22 May 18:00

Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 300 industry, academic, and investment leaders to discuss the must cut…

Read more

Closing the gender gap in biotech funding

Closing the gender gap in biotech funding

Companies with a good gender balance consistently outperform those with only men in their management teams. Yet despite this, start-ups with female founders and management team members are consist…

Read more

Battling antibiotic resistance: are we ready for a bacteriophage revival?

Battling antibiotic resistance: are we ready for a bacteriophage revival?

The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives were saved. But excessive antibiotic use in bot…

Read more

Women in STEM: fixing the leaky pipeline

Women in STEM: fixing the leaky pipeline

Happy International Women’s Day! This year, in honor of the day, we’ve decided to highlight an important and personal topic: the lack of women in STEM. The problem is complicated and leads to a lo…

Read more

Orphan CNS diseases receive attention with new Minoryx site in Belgium

Orphan CNS diseases receive attention with new Minoryx site in Belgium

The Spanish start-up Minoryx Therapeutics recently opened a subsidiary in Belgium to further their research on treatments for rare and orphan diseases. Co-founder and CEO Marc Martinell spoke to B…

Read more

Microbiome linked to depression in a groundbreaking Benelux study

Microbiome linked to depression in a groundbreaking Benelux study

The microbiome had been at the forefront of a lot of research and news in the past few years. Now, a new study published in Nature Microbiology has linked specific microbiome changes with depressi…

Read more

From scientist to entrepreneur: how a Belgian chromatography company came to be

From scientist to entrepreneur: how a Belgian chromatography company came to be

Pharmafluidics is a Belgian company rethinking the fundamentals of liquid chromatography. Introducing a fundamentally new type of stationary phase in its chip-etched columns represented a major in…

Read more

AuXin Surgery Announces the Launch of its new CADISS System for Selective Dissection in Surgery

Louvain-la-Neuve, Belgium, 7 February 2019 – AuXin Surgery, a medical device company, announces that it has obtained CE Class III certification for its novel CADISS® System for the surgery of chro…

Read more

Inari’s agricultural revolution hits Europe with a new site in Ghent

Inari’s agricultural revolution hits Europe with a new site in Ghent

Inari, a U.S. company revolutionizing agricultural R&D, have just opened up their first overseas office in Ghent, Belgium. Partnering with Belgian life sciences and agriculture institutes VIB and …

Read more

Pharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights

PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a…

Read more

Biocartis raises EUR 55.50 million

Biocartis Group NV (the "Company" or "Biocartis"), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today that it successfully raised an amount of EUR 55.50 millio…

Read more

Are we spending too much money on cancer drugs?

Are we spending too much money on cancer drugs?

November is classically the month where immunotherapy takes center stage, especially at the annual conference of the Society for Immunotherapy of Cancer (SITC, endearingly pronounced sitsie).  Imm…

Read more

Join our 20.000 subscribers and receive the monthly newsletter for free!

Upcoming events

JLABS event: Going Up - Successful Elevator Pitches and Investor Interactions

Radisson Blu Astrid Hotel Koningin Astridplein 7 Antwerp 2018
Wed 03 Apr 2019
11:30

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for an in-depth workshop on navigating relations with investors. In this works…

Read more

Global Engage Microbiome & Probiotics Series: Europe

Rotterdam, The Netherlands (venue TBA)
Mon 20 May 2019 - Wed 22 May 2019
20 May 08:00 - 22 May 18:00

Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 300 industry, academic, and investment leaders to discuss the must cut…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Janssen Itera Life Science Biowin KU Leuven XpandInnovation GSK Turnstone UGent Flanders.bio V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.